#161918

SK-MEL-3 Cell Line

Cat. #161918

SK-MEL-3 Cell Line

Cat. #: 161918

Availability: 8-10 weeks

Organism: Human

Tissue: Skin

Model: Tumourigenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lloyd J. Old, Germain Trempe

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SK-MEL-3 Cell Line
  • Cancer: Skin cancer
  • Organism: Human
  • Gender: Female
  • Tissue: Skin
  • Donor: This cell line was established in 1972 from a metastatic site (lymph node) in a 42-year-old Caucasian female with malignant melanoma.
  • Morphology: Fibroblast
  • Growth properties: Adherent
  • Model: Tumourigenic
  • Model description: Tumourigenic in nude mice; forms pigmented malignant melanoma
  • Products or characteristics of interest: Karyotype: (P13) hypotetraploid to hypertetraploid with abnormalities including dicentrics, pulverizations, secondary constrictions and minutes. Isoenzymes: AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 1-2; PGM1, 1-2; PGM3, 1
  • Description: SK-MEL-3 is one of a series of melanoma cell lines established from patient-derived tumour samples. This cell line is known to form tumours in immunocompromised mice.
  • Application: 3D cell culture; High-throughput screening; Toxicology
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type O; Rh+

Applications

  • Application: 3D cell culture; High-throughput screening; Toxicology

Handling

  • Growth medium: McCoy's 5a Medium Modified supplemented with FBS to a final concentration of 15%
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% (v/v) DMSO
  • Storage conditions: Vapor phase of liquid nitrogen
  • Subculture routine: Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to remove all traces of serum, which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the
  • Str profiling: Amelogenin: XCSF1PO: 9,10D13S317: 12,13D16S539: 11D5S818: 11D7S820: 8,10TH01: 6TPOX: 8vWA: 14,18D3S1358: 17,18D21S11: 29,30D18S51: 10,18Penta_E: 11,15Penta_D: 9,13D8S1179: 14FGA: 24D19S433: 15,16.2D2S1338: 19,23

References

  • Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.